INICIO

Continuation of the Revista Mexicana de Cardiología

  • Home
  • Instructions for authors
    • Instructions for authors
    • Regulations for the publication of supplements
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • About Us
    • About the Journal            
    • Publisher Policies
    • Previous Titles
    • Editorial Management
  • Contact





2026, Number 2

Cardiovasc Metab Sci 2026; 37 (2)

Acute myocardial infarction in a young adult living with newly diagnosed human immunodeficiency virus

Dueñaz-Díaz, Isaías G; Morelos-Guzmán, Martha; Aréan-Martínez, Carlos A; Dueñaz-Díaz, Jesús E; Chora-Hernández, Luis D

ABSTRACT

Human immunodeficiency virus (HIV) infection continues to be a major public health problem. However, people living with HIV are surviving to older ages and are presenting with a higher prevalence of cardiovascular disease. HIV infection itself is associated with an increased risk of atherosclerotic cardiovascular disease, most commonly manifesting as acute coronary syndrome, typically at younger ages and often in the absence of traditional cardiovascular risk factors. We present the case of a patient with ST-segment elevation acute coronary syndrome with a history of non-significant tobacco exposure (0.75 pack-years, discontinued six years prior), whose main cardiovascular risk factor was a recent diagnosis of HIV infection. Consequently, this was a treatment-naïve patient with no prior exposure to antiretroviral therapy, consistent with findings from other studies analyzing this population, which describe a low burden of comorbidities, a distinct clinical presentation of the syndrome, and a high thrombus burden at the level of the culprit plaque on coronary angiography.
  FULL TEXT PDF   FLIPBOOK

Keywords

myocardial infarction human immunodeficiency virus young adult cardiovascular diseases




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • A comparative evaluation of sacubitril-valsartan and nebivolol-valsartan in...
    2026, Vol.37, Núm. 2
  • Out-of-hospital cardiac arrests and cardiopulmonary resuscitation. Is there a...
    2026, Vol.37, Núm. 2
  • Catheter ablation of frequent premature ventricular complexes: curative...
    2026, Vol.37, Núm. 2
  • Microplastic and nanoplastic pollution and cardiovascular health
    2026, Vol.37, Núm. 2
  • Acute myocardial infarction in a young adult living with newly diagnosed human...
    2026, Vol.37, Núm. 2
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3


Cardiovascular and Metabolic Science Vol. 37, Num. 2, Abril-Junio 2026. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 http://www.medigraphic.com/cms ancam@ancam.org.mx https://www.medigraphic.com/cms/ E-mail: revmexcardiol@gmail.com Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-022717130200-102. ISSN impreso: 2683-2828, ISSN electrónico: 2954-3835. Otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 18 de junio de 2026.

 

2026     |     https://www.cardiovascularandmetabolicscience.org.mx/